Literature DB >> 33818764

Cancer statistics for the year 2020: An overview.

Jacques Ferlay1, Murielle Colombet1, Isabelle Soerjomataram1, Donald M Parkin2,3, Marion Piñeros1, Ariana Znaor1, Freddie Bray1.   

Abstract

Our study briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020 and summarises the main results. National estimates were calculated based on the best available data on cancer incidence from population-based cancer registries (PBCR) and mortality from the World Health Organization mortality database. Cancer incidence and mortality rates for 2020 by sex and age groups were estimated for 38 cancer sites and 185 countries or territories worldwide. There were an estimated 19.3 million (95% uncertainty interval [UI]: 19.0-19.6 million) new cases of cancer (18.1 million excluding non-melanoma skin cancer) and almost 10.0 million (95% UI: 9.7-10.2 million) deaths from cancer (9.9 million excluding non-melanoma skin cancer) worldwide in 2020. The most commonly diagnosed cancers worldwide were female breast cancer (2.26 million cases), lung (2.21) and prostate cancers (1.41); the most common causes of cancer death were lung (1.79 million deaths), liver (830000) and stomach cancers (769000).
© 2021 Union for International Cancer Control.

Entities:  

Keywords:  GLOBOCAN; cancer; global estimates; incidence; mortality

Year:  2021        PMID: 33818764     DOI: 10.1002/ijc.33588

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  392 in total

1.  piRNA-823 Is a Unique Potential Diagnostic Non-Invasive Biomarker in Colorectal Cancer Patients.

Authors:  Norhan A Sabbah; Wael M Abdalla; Walid A Mawla; Nagla AbdAlMonem; Amal F Gharib; Ahmed Abdul-Saboor; Abdallah S Abdelazem; Nermin Raafat
Journal:  Genes (Basel)       Date:  2021-04-19       Impact factor: 4.096

2.  A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy.

Authors:  Iqra Bano; Moolchand Malhi; Min Zhao; Liviu Giurgiulescu; Hira Sajjad; Marek Kieliszek
Journal:  3 Biotech       Date:  2022-03-29       Impact factor: 2.406

3.  Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.

Authors:  Anna Sanchez; Frédérique Penault-Llorca; Yves-Jean Bignon; Laurent Guy; Dominique Bernard-Gallon
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

Review 4.  Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances.

Authors:  Khaled Mahmoud; Shady Swidan; Mohamed El-Nabarawi; Mahmoud Teaima
Journal:  J Nanobiotechnology       Date:  2022-03-05       Impact factor: 10.435

5.  Novel Pyran-Linked Phthalazinone-Pyrazole Hybrids: Synthesis, Cytotoxicity Evaluation, Molecular Modeling, and Descriptor Studies.

Authors:  M Shaheer Malik; Basim H Asghar; Riyaz Syed; Reem I Alsantali; Moataz Morad; Hatem M Altass; Ziad Moussa; Ismail I Althagafi; Rabab S Jassas; Saleh A Ahmed
Journal:  Front Chem       Date:  2021-05-24       Impact factor: 5.221

6.  Prognostic significance of E-Cadherin, β-Catenin and cyclin D1 in oral squamous cell carcinoma: a tissue microarray study.

Authors:  Natheer Al-Rawi; Muwaffaq Al Ani; Asif Quadri; Zaid Hamdoon; Aktham Awwad; Sausan Al Kawas; Ahmed Al Nuaimi
Journal:  Histol Histopathol       Date:  2021-07-26       Impact factor: 2.303

Review 7.  Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity.

Authors:  Maria P Mogavero; Alessandro Silvani; Lourdes M DelRosso; Michele Salemi; Raffaele Ferri
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 8.  Nanogels as a Versatile Drug Delivery System for Brain Cancer.

Authors:  Brielle Stawicki; Tyler Schacher; Hyunah Cho
Journal:  Gels       Date:  2021-05-26

9.  Multimodal Imaging Techniques to Evaluate the Anticancer Effect of Cold Atmospheric Pressure Plasma.

Authors:  Marcel Kordt; Isabell Trautmann; Christin Schlie; Tobias Lindner; Jan Stenzel; Anna Schildt; Lars Boeckmann; Sander Bekeschus; Jens Kurth; Bernd J Krause; Brigitte Vollmar; Eberhard Grambow
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

10.  Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity in KRAS-Mutant Non-Small Cell Lung Cancer.

Authors:  Yi-Chun Chao; Kang-Yun Lee; Sheng-Ming Wu; Deng-Yu Kuo; Pei-Wei Shueng; Cheng-Wei Lin
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.